To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
Summary
HR10544, introduced September 24, 2026, aims to improve ovarian cancer awareness and access to genetic counseling and testing. Referred to House Energy and Commerce Committee. No funding authorized. Early stage with minimal near-term market impact.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR10544 is an early-stage bill with no funding authorization.
- 2.Focuses on ovarian cancer awareness and genetic testing access.
- 3.Bipartisan cosponsorship but low legislative momentum.
- 4.No immediate market impact; monitor for committee action.
Market Implications
The genetic testing sector may see long-term tailwinds from increased awareness, but this bill alone does not change the near-term revenue outlook for any public company. Companies like Illumina ($ILMN), Guardant Health ($GH), and Exact Sciences ($EXAS) could benefit if the bill leads to increased testing volumes, but that is contingent on passage and funding. Current market trends in the sector are driven by other factors.
Full Analysis
On September 24, 2026, Representative Rosa DeLauro (D-CT-3) introduced HR10544 in the 119th Congress. The bill was referred to the House Committee on Energy and Commerce. It is in early stage with no further action. The bill's title indicates a focus on modernizing federal efforts for ovarian cancer awareness, hereditary cancer risk assessment, and access to genetic counseling and testing. No specific funding amount is authorized; any spending would require a separate appropriations bill. The bill has three cosponsors, including bipartisan support (Rep. Bacon, R-NE-2; Rep. Balint, D-VT; Rep. Fitzpatrick, R-PA-1). Given the early stage and lack of funding details, the near-term market impact is negligible. If the bill advances, it could increase utilization of genetic testing services, potentially benefiting diagnostic and genetic testing companies. However, investors should not adjust positions based on this bill alone. The legislative path includes committee markup, House vote, Senate consideration, and presidential action, which is unlikely in the current session given the late date in 2026.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
A bill to modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
FOUNDATION MEDICINE, INC.: $22.0M Department of Veterans Affairs Contract
Access to Genetic Counselor Services Act of 2025
Reducing Hereditary Cancer Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →